Description
A flavonoid with diverse biological activities; inhibits osteoclast differentiation, bone resorption, activation of NF-κB and NFAT by RANKL, and calcium oscillations in vitro; in vivo administration protects ovariectomized mice from bone loss; reduces lipid accumulation in HepG2 cells and reverses hyperlipidemia in a mouse model of diet-induced obesity; increases glucose tolerance and decreases insulin resistance while simultaneously decreasing serum triglycerides and total cholesterol and inhibiting lipid accumulation in livers in a mouse model of diabetes,
Formal name: (2S)-7-[[2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one
Synonyms: Hesperetin 7-Neohesperidoside|NSC 31048
Molecular weight: 610.6
CAS: 13241-33-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Natural Products|Flavonoids||Research Area|Cardiovascular System|Lipids & Lipoproteins||Research Area|Endocrinology & Metabolism|Bone Growth & Remodeling||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity
